Medartis Holding AG (XSWX:MED) YoY EPS Growth: 441.67% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MED Medartis Holding AG XSWX:MED
82 GF Score
Price CHF90.10
GF Value CHF106.56
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medartis Holding AG YoY EPS Growth?

Medartis Holding AG XSWX:MED -0.33% 82 YoY EPS Growth is 441.67% as of Jun. 2026. GuruFocus rates XSWX:MED with a GF Score™ of 82/100 and a GF Value™ of CHF106.56 (Modestly Undervalued). The stock has 6 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Medartis Holding AG's YoY EPS Growth for the quarter that ended in Jun. 2026 was 441.67%.

Medartis Holding AG's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was CHF0.41.

Medartis Holding AG YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG YoY EPS Growth Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 825.00 -184.48 110.20 460.00 139.29

Medartis Holding AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 400.00 -41.67 -157.14 1,028.57 441.67
XSWX:MED
82GF Score
Medartis Holding AG XSWX:MED
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Medartis Holding AG's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(0.67-0.28)/ | 0.28 |
=139.29 %

Medartis Holding AG's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(0.41--0.12)/ | -0.12 |
=441.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 441.67% mean?
Medartis Holding AG (XSWX:MED) has a YoY EPS Growth of 441.67% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Medartis Holding AG and its competitors.
Is Medartis Holding AG's YoY EPS Growth too high?
Medartis Holding AG's current YoY EPS Growth is 441.67%. Overall, Medartis Holding AG has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's YoY EPS Growth compare to ABT and SYK?
Medartis Holding AG's YoY EPS Growth of 441.67% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Devices & Instruments company?
A good YoY EPS Growth depends on the Medical Devices & Instruments industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Medartis Holding AG and its competitors. Medartis Holding AG's current YoY EPS Growth is 441.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.56, compared to a current price of CHF90.10 — trading 15.4% below its estimated fair value. The current YoY EPS Growth is 441.67%. Medartis Holding AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current YoY EPS Growth is 441.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF90.10 is trading 15.4% below its estimated GF Value™ of CHF106.56. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • YoY EPS Growth: 441.67%
  • GF Value™: CHF106.56 vs. price of CHF90.10 (15.4% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score

Get the complete analysis for XSWX:MED

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF90.10
Price
CHF106.56
GF Value